NCT00426257View on ClinicalTrials.gov

Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 16, 2017

Study Completion Date

August 16, 2017

Conditions
Ovarian Cancer
Interventions
PROCEDURE

Secondary debulking

Secondary debulking

PROCEDURE

secondary debulking with intraperitoneal chemotherapy

secondary debulking with intraperitoneal chemotherapy

Trial Locations (1)

1066CX

The Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
lead

The Netherlands Cancer Institute

OTHER

NCT00426257 - Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer | Biotech Hunter | Biotech Hunter